106 results
Page 5 of 6
6-K
EX-1.1
5rrv3eg wlyk
7 Mar 14
BioLineRx Closes $24.1 Million Underwritten Public Offering
12:00am
424B5
avh4vt 3bq4zq9ho7
4 Mar 14
Prospectus supplement for primary offering
12:00am
424B5
vvdo71u2kr
3 Mar 14
Prospectus supplement for primary offering
12:00am
424B3
neb4fff7w4dn
8 Aug 13
Prospectus supplement
12:00am
424B5
zmgrp3 3v
17 May 13
Prospectus supplement for primary offering
12:00am
424B5
erftdqy568 ha
17 May 13
Prospectus supplement for primary offering
12:00am
424B5
2bkpmx2e40hyifwf
6 Feb 13
Prospectus supplement for primary offering
12:00am
424B3
6blczaixykx tpf
15 Oct 12
Prospectus supplement
12:00am
F-1
32xev3jj8m85to4
2 Oct 12
Registration statement (foreign)
12:00am
6-K
EX-99
5gi0qz49f3lxk
27 Sep 12
Current report (foreign)
12:00am
424B3
c6wkao hxzx
2 Aug 12
Prospectus supplement
12:00am
F-3
4yk64ia648rzmmvn a2
1 Aug 12
Shelf registration (foreign)
12:00am
POS AM
zudfrtmdt2aq3
25 Jul 12
Prospectus update (post-effective amendment)
12:00am
F-3/A
28gxc5snoqrssr
23 Jul 12
Shelf registration (foreign) (amended)
12:00am
424B3
4ub4 2svcob
28 Mar 12
Prospectus supplement
12:00am
20-F
EX-12.2
44z9ms 5utyyc7hadlr
22 Mar 12
Annual report (foreign)
12:00am
20-F
EX-12.1
j69cc0rw6 st3ax
22 Mar 12
Annual report (foreign)
12:00am